Patents by Inventor Morris Faiman

Morris Faiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050037975
    Abstract: Disclosed are novel compounds and novel pharmaceutical compositions for use in medical therapy, as well as intermediates and processes for preparing such compounds. Therapeutic methods for preventing or treating glutamate-related disorders in a mammal and methods to inhibit or prevent glutamate binding in mammalian tissue are also disclosed.
    Type: Application
    Filed: July 25, 2003
    Publication date: February 17, 2005
    Inventors: Morris Faiman, John Schloss, Jang-Yen Wu
  • Publication number: 20030087829
    Abstract: Disclosed are novel compounds and novel pharmaceutical compositions for use in medical therapy, as well as intermediates and processes for preparing such compounds. Therapeutic methods for preventing or treating glutamate-related disorders in a mammal and methods to inhibit or prevent glutamate binding in mammalian tissue are also disclosed.
    Type: Application
    Filed: October 28, 2002
    Publication date: May 8, 2003
    Inventors: Morris Faiman, John V. Schloss, Jang-Yen Wu
  • Publication number: 20010031730
    Abstract: Disclosed are novel compounds and novel pharmaceutical compositions for use in medical therapy, as well as intermediates and processes for preparing such compounds. Therapeutic methods for preventing or treating glutamate-related disorders in a mammal and methods to inhibit or prevent glutamate binding in mammalian tissue are also disclosed.
    Type: Application
    Filed: December 1, 2000
    Publication date: October 18, 2001
    Inventors: Morris Faiman, John V. Schloss, Jang-Yen Wu
  • Patent number: 6156794
    Abstract: A method of using a compound of formula (I) wherein R.sup.1, R.sup.2, R.sup.3, X and n have any of the meanings defined in the specification, to antagonize glutamate binding, or to treat glutamate-related disorders is provided. Novel compounds, intermediates and pharmaceutical compositions are also provided.
    Type: Grant
    Filed: September 13, 1999
    Date of Patent: December 5, 2000
    Inventors: Morris Faiman, John V. Schloss, Jang-Yen Wu